DEA Extends COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for 6 Months
HIT Consultant
MAY 9, 2023
What You Should Know: Today, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities adopted during the COVID-19 public (..)
Let's personalize your content